OMC
SEEL

Oasis Management Company’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Oasis Management Company’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-221
Closed -$577K – 117
2022
Q4 		$577K Hold
221
– – 0.11% 58
2022
Q3 		$876K Hold
221
– – 0.15% 61
2022
Q2 		$578K Buy
+221
New +$576K 0.1% 80

Other funds holding SEEL

GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Oasis Management Company's SEEL Position: Q1 2023 in Review

Oasis Management Company sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q1 2023, closing a stake of 221 shares — an estimated $577K sold.

Oasis Management Company first reported a position in SEEL in Q2 2022 and held it in 3 quarters. The position peaked at $876K in Q3 2022. 60 funds tracked by Wall St. Rank hold SEEL as of Q1 2023.

  • Oasis Management Company reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 221 Seelos Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $577K.
  • Oasis Management Company first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's Seelos Therapeutics, Inc. Common Stock position peaked at $876K in Q3 2022.
  • 60 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.